2B7K:XETRA:XETRA-iShares MSCI World SRI UCITS ETF EUR (Acc) (EUR)

ETF | Others |

Last Closing

USD 10.394

Change

+0.02 (+0.19)%

Market Cap

N/A

Volume

0.30M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-25 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.05 (-0.10%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.41 (+0.44%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.06 (+0.24%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

+0.05 (+0.38%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

+0.05 (+1.00%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

+0.04 (+0.16%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

+0.06 (+0.48%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.90 (-1.58%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.01 (-0.08%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

-0.21 (-0.17%)

USD 12.26B

ETFs Containing 2B7K:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -12.39% 20% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.39% 23% F 23% F
Trailing 12 Months  
Capital Gain -1.29% 31% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.29% 34% F 37% F
Trailing 5 Years  
Capital Gain 72.40% 68% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.40% 69% C- 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 13.18% 78% C+ 76% C+
Dividend Return 13.18% 77% C+ 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.15% 46% F 56% F
Risk Adjusted Return 100.26% 86% B+ 88% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.